13F-HR filed by Vestal Point Capital, LP
Vestal Point Capital, LP filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 69 holding rows worth $1,318,626,521.
- Accession
- 0001974915-24-000011
- Filer
- CIK 1974915
- Filed
- 2024-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 69 entries on the cover page, a total value of $1,318,626,521 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,318,626,521 with VALUE read as dollars as filed, 13F file number 028-23784. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INSMED INC COM PAR $.01 | 457669307 | Stock | 1,600,000 | $116,800,000 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 900,000 | $100,269,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 1,500,000 | $79,200,000 | dollars as filed | |
| INARI MED INC | 45332Y109 | COM | 1,550,000 | $63,922,000 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 675,000 | $56,369,250 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 1,150,000 | $50,473,500 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 4,000,000 | $46,320,000 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 4,000,000 | $44,040,000 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 3,750,000 | $42,787,500 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 750,000 | $41,662,500 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 250,000 | $37,327,500 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 720,000 | $36,352,800 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 2,500,000 | $34,825,000 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 8,090,000 | $34,301,600 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 760,000 | $33,766,800 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 825,000 | $32,480,250 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 400,000 | $28,116,000 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 2,000,000 | $26,230,000 | dollars as filed | put |
| BIOHAVEN LTD | G1110E107 | COM | 500,000 | $24,985,000 | dollars as filed | call |
| UNIQURE NV | N90064101 | SHS | 4,750,000 | $23,417,500 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 485,000 | $22,033,550 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 5,028,500 | $21,873,975 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 2,800,000 | $19,516,000 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 275,000 | $18,147,250 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 200,000 | $16,768,000 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 1,500,000 | $15,000,000 | dollars as filed | |
| AGILENT TECHNOLOGIES INC COM | 00846U101 | Stock | 100,000 | $14,848,000 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 250,000 | $12,935,000 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 300,000 | $12,264,000 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 425,000 | $10,824,750 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 395,000 | $10,815,100 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 205,000 | $10,475,500 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 1,025,000 | $10,465,250 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 1,145,000 | $9,732,500 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 425,000 | $9,549,750 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 150,000 | $8,644,500 | dollars as filed | |
| BRUKER CORP | 116794108 | COM | 125,000 | $8,632,500 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 136,500 | $8,018,010 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 615,000 | $7,718,250 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 850,000 | $7,684,000 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 230,000 | $7,564,700 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 650,000 | $7,436,000 | dollars as filed | |
| BECTON DICKINSON & CO | 075887109 | COM | 30,000 | $7,233,000 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 30,000 | $6,366,600 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 125,000 | $6,091,250 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 1,685,000 | $5,897,500 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 180,000 | $5,182,200 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 400,000 | $5,080,000 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 930,000 | $4,929,000 | dollars as filed | |
| GERON CORP | 374163103 | COM | 1,050,000 | $4,767,000 | dollars as filed | |
| PASSAGE BIO INC | 702712100 | COM | 6,100,000 | $4,270,000 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 1,500,000 | $4,200,000 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 1,070,000 | $4,140,900 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 1,725,000 | $3,760,500 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 525,000 | $3,643,500 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 500,000 | $3,445,000 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 80,000 | $2,968,000 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 15,000 | $2,914,650 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 490,000 | $2,866,500 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 830,000 | $2,730,700 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 525,000 | $2,541,000 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 30,000 | $2,195,100 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 40,000 | $1,730,800 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 490,000 | $1,587,600 | dollars as filed | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 1,500,000 | $1,530,000 | dollars as filed | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 799,400 | $1,358,980 | dollars as filed | |
| CHIMERIX INC COM | 16934W106 | Stock | 1,400,000 | $1,302,000 | dollars as filed | |
| ATARA BIOTHERAPEUTICS INC | 046513206 | COM NEW | 124,677 | $1,013,624 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 83,333 | $288,332 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001974915-24-000011 | this filing | 2024-11-14 | acceptance time not in the bulk data set |